Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Teva | Topotecan | Topotecan Teva | 2009-09-21 | |||
Novast Laboratories | Topotecan | Topotecan | 2016-11-30 | |||
Rising Pharmaceuticals | Topotecan | Topotecan | 2012-08-28 | |||
Roche | Atezolizumab | Tecentriq | 2017-09-20 | $4,406.336 M | Q4/22-Q3/23 | |
Sandoz | Topotecan | Hycamtin | 1996-05-28 | |||
Topotecan | Topotecan | 2011-02-25 | ||||
Pfizer | Topotecan | Topotecan Hospira | 2010-06-09 | |||
Dr Reddys Laboratories | Topotecan | Topotecan | 2011-03-09 | |||
Sun Pharmaceutical Industries | Topotecan | Topotecan | 2013-08-29 | |||
Hospira | Topotecan | Topotecan | 2011-02-02 | |||
Accord Healthcare | Topotecan | Topotecan | 2013-06-26 |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|